Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Phototherapy.
- Who it may be relevant to
- Registry conditions: Neonatal Hyperbilirubinemia. Basic parameters: 1 Day — 28 Days · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in NICU
Overview
Early detection and prevention of neonatal encephalopathy using BIND score.
Interventions
- Device Phototherapy
Phototherapy used to decrease high billirubin level in neonatal jaundice
Primary outcome measures
- Decrease high billirubin level [Time frame: One year duration]
- Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU [Time frame: Baseline]
- Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU [Time frame: Baseline]
Eligibility criteria
Inclusion criteria
Newborn < 28 days old Neonates with severe hyperbilirubinemia need extensive phototherapy impending exchange transfusion
Exclusion criteria
Age > 28 days old Neonates with any abnormal neurological signs suggesting neurological disease (hypoxic ischemic encephalopathy, muscle disease, …etc.).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Vongbhavit K, Rearkyai S, Janyoungsak P, Panburana J. Impact of 2022 AAP Neonatal Hyperbilirubinemia Guidelines in a Middle-Income Country: A Single-Center Study in Thailand. Neonatology. 2025;122(6):660-668. doi: 10.1159/000547630. Epub 2025 Aug 13. PMID 40815110
Identifiers
NCT: NCT07150494 · Neonatal jaundice cases in nic